| Basics |
| Company: |
NORTHWEST BIOTHERAPEUTICS INC |
| IPO Date: |
January 1, 2002 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 3.68%
|
| Avg Daily Range (30 D): |
$0.01 | 4.02%
|
| Avg Daily Range (90 D): |
$0.01 | 4.38%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.69M |
| Avg Daily Volume (30 D): |
3.02M |
| Avg Daily Volume (90 D): |
2.54M |
| Trade Size |
| Avg Trade Size (Sh.): |
813 |
| Avg Trade Size (Sh.) (30 D): |
5,638 |
| Avg Trade Size (Sh.) (90 D): |
5,313 |
| Institutional Trades |
| Total Inst.Trades: |
48 |
| Avg Inst. Trade: |
$1.49M |
| Avg Inst. Trade (30 D): |
$.55M |
| Avg Inst. Trade (90 D): |
$.55M |
| Avg Inst. Trade Volume: |
.34M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.47M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
617.26K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2016 |
Q3 2016 |
|
Basic EPS
|
$-.02
|
|
$-.28
|
|
Diluted EPS
|
$-.02
|
|
$-.28
|
|
Revenue
|
$ .28M
|
$ .07M
|
$ .16M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -18.3M
|
$ -30.71M
|
$ -29.23M
|
|
Operating Income / Loss
|
$ -15.74M
|
$ -21.25M
|
$ -25.52M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -.56M
|
$ 4.83M
|
$ 9.8M
|
|
PE Ratio
|
|
|
|
| Splits |
| Sep 26, 2012:
16:1
|
| Jun 28, 2007:
15:1
|
|
